The global Autoimmune Diseases Market size is projected to reach a CAGR of 6.5% from 2022-2028.
An autoimmune disease causes the immune system to destroy its own body tissue. There are more than 80 different types of autoimmune disorders; however, lupus, multiple sclerosis, IBS, type 1 diabetes, rheumatoid arthritis, psoriasis, and others are the most common form of autoimmune disease. Different types of drugs such as anti-inflammatory, NSAIDs, interferons, immune suppressants, corticosteroids, and others, are approved for the treatment of autoimmune disease.
Increase in incidence of autoimmune disease, surge in adoption of autoimmune disease therapeutics, and growth in R&D activities to develop ideal therapeutics are some of the factors that have supported long-term expansion for Autoimmune Diseases Market.
Asia-Pacific presents lucrative growth opportunities for the key players operating in the autoimmune disease therapeutics market owing to large population base, rise in purchasing power, surge in prevalence of autoimmune disease, and increase in demand for advanced autoimmune disease therapeutics.
Insights are provided for each region and major countries within the regions
|
Report Feature |
Descriptions |
|---|---|
|
Growth Rate |
CAGR of 6.5% during the forecasting period, 2022-2028 |
|
Historical Data |
2019-2020 |
|
Forecast Years |
2022-2028 |
|
Base Year |
2021 |
|
Units Considered |
Revenue in USD million and CAGR from 2022 to 2028 |
|
Report Segmentation |
sales channel, indication, drug class type and region. |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
AstraZeneca plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, Pfizer Inc., UCB S.A. |
|
Available Customization |
In addition to the market data for Autoimmune Diseases Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Autoimmune Diseases Market is segmented into sales channel, indication, drug class type and region.
.png)
.png)
.png)
.png)
.png)
.png)